Stay updated with breaking news from Ucb Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Case Name: UCB, Inc. v. Mylan Techs. Inc., Civ. No. 22-cv-216 (D. Vt. Mar. 8, 2024) (Reiss, J.) - Drug Product and Patent(s)-in-Suit: Neupro® (rotigotine); U.S. Patents Nos. 8,246,979...
UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology Annual Meeting Diverse and...
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the...
The products include Pilocarpine Hydrochloride Ophthalmic Solution 0.4%, Tenapanor, Zilucoplan, and Bimekizumab-bkzx.
ZILBRYSQ® is now commercially available by prescription in the United States and dispensed by UCB's selected exclusive specialty pharmacy PANTHERx® Rare Pharmacy.ZILBRYSQ is FDA-approved as the...